Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Genetic study of circulating cytokines offers insight into the determinants, cascades and effects of systemic inflammation

View ORCID ProfileVille Karhunen, View ORCID ProfileDipender Gill, Rainer Malik, View ORCID ProfileMark J. Ponsford, Ari Ahola-Olli, Areti Papadopoulou, Saranya Palaniswamy, Shivaprakash Jagalur Mutt, Sylvain Sebert, Minna Männikkö, Juha Auvinen, Juha Veijola, Karl-Heinz Herzig, Markku Timonen, Sirkka Keinänen-Kiukaanniemi, Martin Dichgans, Marko Salmi, Sirpa Jalkanen, Terho Lehtimäki, Veikko Salomaa, Olli Raitakari, Simon A Jones, Konstantinos K. Tsilidis, Marjo-Riitta Järvelin, Abbas Dehghan
doi: https://doi.org/10.1101/2020.10.26.20219477
Ville Karhunen
1Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ville Karhunen
Dipender Gill
1Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Dipender Gill
Rainer Malik
2Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark J. Ponsford
3Division of Immunology, Infection, and Inflammation, Tenovus Institute, Cardiff University, Cardiff, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mark J. Ponsford
Ari Ahola-Olli
4The Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA
5Analytical and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA, USA
6Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Areti Papadopoulou
7William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Saranya Palaniswamy
1Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK
8Center for Life Course Health Research, Faculty of Medicine, University of Oulu, Oulu, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shivaprakash Jagalur Mutt
9Research Unit of Biomedicine, Medical Research Center (MRC), University of Oulu, University Hospital, Oulu, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sylvain Sebert
8Center for Life Course Health Research, Faculty of Medicine, University of Oulu, Oulu, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Minna Männikkö
10Northern Finland Birth Cohorts, Infrastructure for Population Studies, Faculty of Medicine, University of Oulu, Oulu, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Juha Auvinen
8Center for Life Course Health Research, Faculty of Medicine, University of Oulu, Oulu, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Juha Veijola
11Department of Psychiatry, Research Unit of Clinical Neuroscience, University of Oulu & Department of Psychiatry, University Hospital of Oulu, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karl-Heinz Herzig
9Research Unit of Biomedicine, Medical Research Center (MRC), University of Oulu, University Hospital, Oulu, Finland
12Department of Gastroenterology and Metabolism, Poznan University of Medical Sciences, Poznan, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Markku Timonen
8Center for Life Course Health Research, Faculty of Medicine, University of Oulu, Oulu, Finland
13Unit of Primary Care, Oulu University Hospital, Oulu, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sirkka Keinänen-Kiukaanniemi
8Center for Life Course Health Research, Faculty of Medicine, University of Oulu, Oulu, Finland
13Unit of Primary Care, Oulu University Hospital, Oulu, Finland
14Healthcare and Social Services of Selänne, Pyhäjärvi, Finland and city of Oulu, Oulu, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin Dichgans
2Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany
15Munich Cluster for Systems Neurology (SyNergy), Munich, Germany
16German Centre for Neurodegenerative Diseases (DZNE), Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marko Salmi
17MediCity and Institute of Biomedicine, University of Turku, Turku, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sirpa Jalkanen
17MediCity and Institute of Biomedicine, University of Turku, Turku, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Terho Lehtimäki
18Department of Clinical Chemistry, Fimlab Laboratories, and Finnish Cardiovascular Research Center, Tampere, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Veikko Salomaa
19Finnish Institute for Health and Welfare, Helsinki, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Olli Raitakari
20Research Centre of Applied and Preventive Cardiovascular Medicine, University of Turku, Turku, Finland
21Department of Clinical Physiology and Nuclear Medicine, Turku University Hospital, Turku, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Simon A Jones
3Division of Immunology, Infection, and Inflammation, Tenovus Institute, Cardiff University, Cardiff, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Konstantinos K. Tsilidis
1Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK
22Department of Hygiene and Epidemiology, University of Ioannina Medical School, Ioannina, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marjo-Riitta Järvelin
1Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK
8Center for Life Course Health Research, Faculty of Medicine, University of Oulu, Oulu, Finland
13Unit of Primary Care, Oulu University Hospital, Oulu, Finland
23MRC Centre for Environment and Health, School of Public Health, Imperial College London, London, UK
24Biocenter Oulu, University of Oulu, Oulu, Finland
25Department of Life Sciences, College of Health and Life Sciences, Brunel University London, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: m.jarvelin@imperial.ac.uk
Abbas Dehghan
1Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK
23MRC Centre for Environment and Health, School of Public Health, Imperial College London, London, UK
26UK Dementia Research Institute at Imperial College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Cytokines are the signalling molecules that underlie inflammatory processes. Here, we performed genome-wide association study (GWAS) analyses of 47 circulating cytokines in up to 13,365 individuals to identify protein quantitative trait loci (pQTL). Applying a novel approach, we incorporated pQTL and expression quantitative trait loci (eQTL) data of 10,361 tissue samples in 635 individuals to identify biologically plausible genetic instruments to proxy the effect of cytokines. Using Mendelian randomization analysis, we explored the causal determinants of inflammatory cytokines, investigated inflammatory cascades and evaluated their effects on 20 diseases. We show evidence of body mass index (BMI), smoking and systolic blood pressure (SBP) being associated with inflammation, and specifically BMI affecting levels of active PAI-1, HGF, MCP1, sE-Selectin, sICAM1, TRAIL, IL6 and CRP. Our analysis highlights a key role of VEGF in influencing the levels of eight other inflammatory cytokines. Finally, we report evidence of sICAM affecting waist circumference and risk of major depressive disorder, evidence for TRAIL affecting the risk of cardiovascular diseases, breast and prostate cancer, and evidence for MIG affecting the risk of stroke. Overall, our results offer insight into inflammatory mediators of BMI, smoking and SBP, pleiotropic effects of VEGF, and circulating cytokines that increase the risk of cancer, cardiovascular, metabolic and neuropsychiatric diseases. All the studied cytokines represent pharmacological targets and therefore offer opportunities for clinical translation in diseases with inflammatory components.

Competing Interest Statement

DG is employed part-time by Novo Nordisk. VS has received honoraria from Novo Nordisk and Sanofi for consultations and travel support from Novo Nordisk. He also has ongoing research collaboration with Bayer Ltd. These are all unrelated to the present study. The remaining authors have no conflicts of interest to declare.

Funding Statement

VK is funded by the European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant (721567). DG was supported by the Wellcome Trust 4i Programme (203928/Z/16/Z) and British Heart Foundation Centre of Research Excellence (RE/18/4/34215) at Imperial College London. MP is a funded by the Welsh Clinical Academic Training (WCAT) programme and is a participant in the NIH Graduate Partnership Program. VS was supported by the Finnish Foundation for Cardiovascular Research. SP is funded by the the European Union's Horizon 2020 Framework EDCMET (825762), iHealth-T2D (643774), Yrjo Jahnsson Foundation and Paivikki and Sakari Sohlberg Foundation. KKT was supported by Cancer Research UK (C18281/A29019). MRJ is funded by the European Union's Horizon 2020 programmes: EDCMET (825762), DynaHEALTH (633595), LifeCycle, iHealth-T2D (643774), LongITools (874739) and Medical Research Council/Biotechnology and Biological Sciences Research Council (PREcisE, MR/M013138/1, MR/S03658X/1, under Nutrition & Epigenome, The Joint Programming Initiative a Healthy Diet for a Healthy Life (JPI HDHL/EU-H2020, project number 665)). AD is funded by the Wellcome Trust seed award (206046/Z/17/Z). This project has also received funding from the European Union's Horizon 2020 research and innovation programme (666881), SVDs@target (to MD; 667375), CoSTREAM (to MD); the DFG as part of the Munich Cluster for Systems Neurology (SyNergy, EXC EXC 2145 SyNergy - ID 390857198), the CRC 1123 (B3; to MD) and project DI 722/13-1; the Corona Foundation (to MD); the LMUexcellent fond (to MD); the e:Med program (e:AtheroSysMed; to MD) and the FP7/2007-2103 European Union project CVgenes@target (grant agreement number Health-F2-2013-601456; to MD). NFBC1966 received core funding for data generation and curation from the Academy of Finland (285547 (EGEA)), University Hospital Oulu, Finland (65354, 75617), Biocenter Oulu, Finland. The NFBCs are also funded by EU-H2020 EUCAN Connect (824989). The Young Finns Study has been financially supported by the Academy of Finland: grants 322098, 286284, 134309 (Eye), 126925, 121584, 124282, 129378 (Salve), 117787 (Gendi), and 41071 (Skidi); the Social Insurance Institution of Finland; Competitive State Research Financing of the Expert Responsibility area of Kuopio, Tampere and Turku University Hospitals (X51001); Juho Vainio Foundation; Paavo Nurmi Foundation; Finnish Foundation for Cardiovascular Research; Finnish Cultural Foundation; The Sigrid Juselius Foundation; Tampere Tuberculosis Foundation; Emil Aaltonen Foundation; Yrjo Jahnsson Foundation; Signe and Ane Gyllenberg Foundation; Diabetes Research Foundation of Finnish Diabetes Association; EU Horizon 2020 (755320 for TAXINOMISIS and 848146 for To Aition); European Research Council (742927 for MULTIEPIGEN project); and Tampere University Hospital Supporting Foundation. The original cytokine measurements were funded by Academy of Finland (141136).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

All study cohorts used in this work had already obtained relevant ethical approval and written participant consent.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Sources of Funding VK is funded by the European Union’s Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant (721567). DG was supported by the Wellcome Trust 4i Programme (203928/Z/16/Z) and British Heart Foundation Centre of Research Excellence (RE/18/4/34215) at Imperial College London. MP is a funded by the Welsh Clinical Academic Training (WCAT) programme and is a participant in the NIH Graduate Partnership Program. VS was supported by the Finnish Foundation for Cardiovascular Research. SP is funded by the the European Union’s Horizon 2020 Framework EDCMET (825762), iHealth-T2D (643774), Yrjö Jahnsson Foundation and Päivikki and Sakari Sohlberg Foundation. KKT was supported by Cancer Research UK (C18281/A29019). MRJ is funded by the European Union’s Horizon 2020 programmes: EDCMET (825762), DynaHEALTH (633595), LifeCycle (), iHealth-T2D (643774), LongITools (874739) and Medical Research Council/Biotechnology and Biological Sciences Research Council (PREcisE, MR/M013138/1, MR/S03658X/1, under Nutrition & Epigenome, The Joint Programming Initiative a Healthy Diet for a Healthy Life (JPI HDHL/EU-H2020, project number 665)). AD is funded by the Wellcome Trust seed award (206046/Z/17/Z).

    This project has also received funding from the European Union’s Horizon 2020 research and innovation programme (666881), SVDs@target (to MD; 667375), CoSTREAM (to MD); the DFG as part of the Munich Cluster for Systems Neurology (SyNergy, EXC EXC 2145 SyNergy – ID 390857198), the CRC 1123 (B3; to MD) and project DI 722/13-1; the Corona Foundation (to MD); the LMUexcellent fond (to MD); the e:Med program (e:AtheroSysMed; to MD) and the FP7/2007-2103 European Union project CVgenes@target (grant agreement number Health-F2-2013-601456; to MD). NFBC1966 received core funding for data generation and curation from the Academy of Finland (285547 (EGEA)), University Hospital Oulu, Finland (65354, 75617), Biocenter Oulu, Finland. The NFBCs are also funded by EU-H2020 EUCAN Connect (824989).

    The Young Finns Study has been financially supported by the Academy of Finland: grants 322098, 286284, 134309 (Eye), 126925, 121584, 124282, 129378 (Salve), 117787 (Gendi), and 41071 (Skidi); the Social Insurance Institution of Finland; Competitive State Research Financing of the Expert Responsibility area of Kuopio, Tampere and Turku University Hospitals (X51001); Juho Vainio Foundation; Paavo Nurmi Foundation; Finnish Foundation for Cardiovascular Research; Finnish Cultural Foundation; The Sigrid Juselius Foundation; Tampere Tuberculosis Foundation; Emil Aaltonen Foundation; Yrjö Jahnsson Foundation; Signe and Ane Gyllenberg Foundation; Diabetes Research Foundation of Finnish Diabetes Association; EU Horizon 2020 (755320 for TAXINOMISIS and 848146 for To Aition); European Research Council (742927 for MULTIEPIGEN project); and Tampere University Hospital Supporting Foundation. The original cytokine measurements were funded by Academy of Finland (141136).

Data Availability

All supporting data for this work are available within the article, its supplementary files and the citations provided. The GWAS summary statistics generated in this work will be made publicly available upon the publication of the article. All study cohorts used in this work had already obtained relevant ethical approval and written participant consent.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted October 31, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Genetic study of circulating cytokines offers insight into the determinants, cascades and effects of systemic inflammation
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Genetic study of circulating cytokines offers insight into the determinants, cascades and effects of systemic inflammation
Ville Karhunen, Dipender Gill, Rainer Malik, Mark J. Ponsford, Ari Ahola-Olli, Areti Papadopoulou, Saranya Palaniswamy, Shivaprakash Jagalur Mutt, Sylvain Sebert, Minna Männikkö, Juha Auvinen, Juha Veijola, Karl-Heinz Herzig, Markku Timonen, Sirkka Keinänen-Kiukaanniemi, Martin Dichgans, Marko Salmi, Sirpa Jalkanen, Terho Lehtimäki, Veikko Salomaa, Olli Raitakari, Simon A Jones, Konstantinos K. Tsilidis, Marjo-Riitta Järvelin, Abbas Dehghan
medRxiv 2020.10.26.20219477; doi: https://doi.org/10.1101/2020.10.26.20219477
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Genetic study of circulating cytokines offers insight into the determinants, cascades and effects of systemic inflammation
Ville Karhunen, Dipender Gill, Rainer Malik, Mark J. Ponsford, Ari Ahola-Olli, Areti Papadopoulou, Saranya Palaniswamy, Shivaprakash Jagalur Mutt, Sylvain Sebert, Minna Männikkö, Juha Auvinen, Juha Veijola, Karl-Heinz Herzig, Markku Timonen, Sirkka Keinänen-Kiukaanniemi, Martin Dichgans, Marko Salmi, Sirpa Jalkanen, Terho Lehtimäki, Veikko Salomaa, Olli Raitakari, Simon A Jones, Konstantinos K. Tsilidis, Marjo-Riitta Järvelin, Abbas Dehghan
medRxiv 2020.10.26.20219477; doi: https://doi.org/10.1101/2020.10.26.20219477

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (160)
  • Allergy and Immunology (412)
  • Anesthesia (90)
  • Cardiovascular Medicine (855)
  • Dentistry and Oral Medicine (156)
  • Dermatology (97)
  • Emergency Medicine (247)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (392)
  • Epidemiology (8534)
  • Forensic Medicine (4)
  • Gastroenterology (381)
  • Genetic and Genomic Medicine (1739)
  • Geriatric Medicine (167)
  • Health Economics (370)
  • Health Informatics (1234)
  • Health Policy (618)
  • Health Systems and Quality Improvement (467)
  • Hematology (196)
  • HIV/AIDS (369)
  • Infectious Diseases (except HIV/AIDS) (10271)
  • Intensive Care and Critical Care Medicine (552)
  • Medical Education (192)
  • Medical Ethics (51)
  • Nephrology (210)
  • Neurology (1666)
  • Nursing (97)
  • Nutrition (247)
  • Obstetrics and Gynecology (325)
  • Occupational and Environmental Health (450)
  • Oncology (925)
  • Ophthalmology (262)
  • Orthopedics (100)
  • Otolaryngology (172)
  • Pain Medicine (110)
  • Palliative Medicine (40)
  • Pathology (249)
  • Pediatrics (534)
  • Pharmacology and Therapeutics (246)
  • Primary Care Research (205)
  • Psychiatry and Clinical Psychology (1757)
  • Public and Global Health (3825)
  • Radiology and Imaging (622)
  • Rehabilitation Medicine and Physical Therapy (317)
  • Respiratory Medicine (518)
  • Rheumatology (207)
  • Sexual and Reproductive Health (164)
  • Sports Medicine (156)
  • Surgery (190)
  • Toxicology (36)
  • Transplantation (100)
  • Urology (74)